CRISPR Therapeutics AG (NASDAQ:CRSP)

Add to Watch List
Set Alert
49.44
Delayed Data
As of 3:59pm ET
 -1.44 / -2.83%
Today’s Change
33.55
Today|||52-Week Range
74.00
-18.82%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 81.50, with a high estimate of 104.00 and a low estimate of 52.00. The median estimate represents a +64.85% increase from the last price of 49.44.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.05
Sales
$5.2M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -304.97%
 
 
 
 
 
 
Growthannually -478.66%
 
 
 
 
 
 

Sales

Growthquarterly -93.22%
 
 
 
 
 
 
Growthannually -92.94%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.